| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1374706 | Bioorganic & Medicinal Chemistry Letters | 2006 | 7 Pages |
Recently, we reported potent and small-sized β-secretase (BACE1) inhibitors KMI-420 and KMI-429 in which we replaced the Glu residue at the P4 position of KMI-260 and KMI-360, respectively, with a 1H-tetrazole-5-carbonyl DAP (l-α,β-diaminopropionic acid) residue. At the P1′ position, these compounds contain one or two carboxylic acid groups, which are unfavorable for crossing the blood–brain barrier. Herein, we report BACE1 inhibitors with P1′ carboxylic acid bioisosteres in order to develop practical anti-Alzheimer’s disease drugs. Among them, tetrazole ring-containing compounds, KMI-570 (IC50 = 4.8 nM) and KMI-684 (IC50 = 1.2 nM), exhibited significantly potent BACE1 inhibitory activities.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
